Genotoxicity of Nanoparticles - Biointeractions of Nanomaterials - page 361

Doak, S.H., Griffiths, S.M., Manshian, B. et al. 2009. Confounding experimental considerations in nanogeno-
toxicology. Mutagenesis 24:285-93.
Doak, S.H., Manshian, B., Jenkins, G.J., and N. Singh. 2012. In vitro genotoxicity testing strategy for nanoma-
terials and the adaptation of current OECD guidelines. Mutat. Res. 745:104-11.
Donaldson, K., Poland, C.A., and R.P. Schins. 2010. Possible genotoxic mechanisms of nanoparticles: Criteria
for improved test strategies. Nanotoxicology 4:414-20.
Downs, T.R., Crosby, M.E., Hu, T. et al. 2012. Silica nanoparticles administered at the maximum tolerated dose
induce genotoxic effects through an inflammatory reaction while gold nanoparticles do not. Mutat. Res.
745:38-50.
Durnev, A.D. 2008. Toxicology of nanoparticles. Bull. Exp. Biol. Med. 145:72-4.
Friedberg, E.C., Walker, G.C., Siede, W., Wood, R.D., Schultz, R.A., and T. Ellenberger. 2006. DNA Repair and
Mutagenesis . ASM Press, Washington.
Ghosh, M., Bandyopadhyay, M., and A. Mukherjee. 2010. Genotoxicity of titanium dioxide (TiO 2 ) nanopar-
ticles at two trophic levels: Plant and human lymphocytes. Chemosphere 81:1253-62.
Gonzalez, L., Sanderson, B.J., and M. Kirsch-Volders. 2011. Adaptations of the in vitro MN assay for the geno-
toxicity assessment of nanomaterials. Mutagenesis 26:185-91.
Gratton, S.E., Ropp, P.A., Pohlhaus, P.D. et al. 2008. The effect of particle design on cellular internalization
pathways. Proc. Natl. Acad. Sci. U.S.A. 105:11613-8.
Greim, H., Borm, P., Schins, R. et al. 2001. Toxicity of fibers and particles. Report of the workshop held in
Munich, Germany, October 26-27, 2000. Inhal. Toxicol. 13:737-54.
Hartmann, A., Agurell, E., Beevers, C. et al. 2003. Recommendations for conducting the in vivo alkaline comet
assay. 4th International Comet Assay Workshop. Mutagenesis 18:45-51.
Hong, S.C., Lee, J.H., Lee, J. et al. 2011. Subtle cytotoxicity and genotoxicity differences in superparamagnetic
iron oxide nanoparticles coated with various functional groups. Int. J. Nanomedicine 6:3219-31.
International Conference on Harmonisation (ICH). 2011. Harmonised Tripartite guideline S2 (R1). Guidance
on genotoxicity testing and data interpretation for pharmaceuticals intended for human use.
Jomini, S., Lebille, J., Bauda, P., and C. Pagnout. 2012. Modifications of the bacterial reverse mutation test
reveals mutagenicity of TiO 2 nanoparticles and byproducts from a sunscreen TiO 2 -based nanocomposite.
Toxicol. Lett. 215:54-61.
Jugan, M.-L., Barillet, S., Simon-Deckers, A. et al. 2012. Titanium dioxide nanoparticles exhibit genotoxicity
and impair DNA repair activity in A549 cells. Nanotoxicology 6:501-13.
Kim, J.S., Song, K.S., Joo, H.J., Lee, J.H., and I.J. Yu. 2010a. Determination of cytotoxicity attributed to
multiwall carbon nanotubes (MWCNT) in normal human embryonic lung cell (WI-38) line. J. Toxicol.
Environ. Health. 73:1521-9.
Kim, S., Seong, K., Kim, O. et al. 2010b. Polyoxalate nanoparticles as a biodegradable and biocompatible drug
delivery vehicle. Biomacromolecules 11:555-60.
Kim, Y.S., Kim, J.S., Cho, H.S. et al. 2008. Twenty-eight-day oral toxicity, genotoxicity, and gender-related
tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 20:575-83.
Konczol, M., Ebeling, S., Goldenberg, E. et al. 2011. Cytotoxicity and genotoxicity of size-fractionated iron
oxide (magnetite) in A549 human lung epithelial cells: Role of ROS, JNK, and NF-jB. Chem. Res.
Toxicol. 24:1460-75.
Landsiedel, R., Kapp, M.D., Schulz, M., Wiench, K., and F. Oesch. 2009. Genotoxicity investigations on nano-
materials: Methods, preparation and characterization of test material, potential artifacts and limitations—
Many questions, some answers. Mutat. Res. 681:241-58.
Lewis, D.J., Bruce, C., Bohic, S. et al. 2010. Intracellular synchrotron nanoimaging and DNA damage/geno-
toxicity screening of novel lanthanide &endash;coated nanovectors. Nanomedicine (Lond). 5:1547-57.
Liu, W., Chaurand, P., Di Giorgio, C. et al. 2012. Influence of the length of imogolite-like nanotubes on their
cytotoxicity and genotoxicity toward human dermal cells. Chem. Res. Toxicol. 25:2513-22.
Magdolenova, Z., Bilanicova, D., Pojana, G. et al. 2012. Impact of agglomeration and different dispersions of
titanium dioxidenanoparticles on the human related in vitro cytotoxicity and genotoxicity. J. Environ.
Monit. 14:455-64.
Merhi, M., Dombu, C.Y., Brient, A. et al. 2012. Study of serum interaction with a cationic nanoparticle:
Implications for in vitro endocytosis, cytotoxicity and genotoxicity. Int. J. Pharm. 423:37-44.
Nabeshi, H., Yoshikawa, T., Matsuyama, K. et al. 2011. Amorphous nanosilica induce endocytosis-dependent
ROS generation and DNA damage in human keratinocytes. Part. Fibre Toxicol. 8:1.
Nam, S.-H., Kim, S.W., and Y.-J. An. 2013. No evidence of the genotoxic potential of gold, silver, zinc oxide
and titanium dioxide nanoparticles in the SOS chromotest. J. Appl. Toxicol . 33:1061-1069.